相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis
Yasuhiko Hirabayashi
MODERN RHEUMATOLOGY (2021)
Comparison of the effects of tocilizumab monotherapy and adalimumab in combination with methotrexate on bone erosion repair in rheumatoid arthritis
Stephanie Finzel et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Pre-treatment interleukin-6 levels strongly affect bone erosion progression and repair detected by magnetic resonance imaging in rheumatoid arthritis patients
Yasushi Kondo et al.
RHEUMATOLOGY (2017)
Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiographic results from the randomised, placebo-controlled FUNCTION trial
Gerd R. Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial
Johannes W. J. Bijlsma et al.
LANCET (2016)
Clinical and structural remission rates increased annually and radiographic progression was continuously inhibited during a 3-year administration of tocilizumab in patients with rheumatoid arthritis: A multi-center, prospective cohort study by the Michinoku Tocilizumab Study Group
Yasuhiko Hirabayashi et al.
MODERN RHEUMATOLOGY (2016)
Evaluation of Serum Interleukin-6 Level as a Surrogate Marker of Synovial Inflammation and as a Factor of Structural Progression in Early Rheumatoid Arthritis: Results From a French National Multicenter Cohort
Athan Baillet et al.
ARTHRITIS CARE & RESEARCH (2015)
Dramatic radiographic repair by tocilizumab in a very elderly patient with rheumatoid arthritis
Ryu Watanabe et al.
MODERN RHEUMATOLOGY (2014)
The Pathological and Physiological Roles of IL-6 Amplifier Activation
Masaaki Murakami et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): Evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
Norihiro Nishimoto et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
分享论文
